PR Newswire
BOSTON, Feb. 27, 2023
BOSTON, Feb. 27, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 44th Annual Institutional Investors Conference on Monday, March 6, 2023, at 8:40 a.m. ET.
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at: https://wsw.com/webcast/rj127/hae/1443508. A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury
(781) 356-9763
[email protected]
David Trenk, Manager-Investor Relations
(203) 733-4987
[email protected]
Media Contact:
Josh Gitelson, Director-Global Communications
(781) 356-9776
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-raymond-james-44th-annual-institutional-investors-conference-301757058.html
SOURCE Haemonetics Corporation
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member